The death of differentiated neurons during their formation of synaptic connections has been widely documented and forms the basis of the trophic theory of nervous system development, in which an initial overproduction of neurons is followed by the death of neurons that do not establish functional synaptic connections. Recently, it has been shown that many neural precursor cells (NPC) die while still in a proliferative state, before having differentiated into neurons. DNA damage, including double-strand breaks, occurs in NPC during brain development and can either be successfully repaired or can trigger a form of programmed cell death called apoptosis. D'Sa-Eipper and coworkers 1xDNA damage-induced neural precursor cell apoptosis requires p53 and caspase-9 but neither Bax nor caspase-3. D'Sa-Eipper, C. et al. Development. 2001; 128: 137–146PubMedSee all References1 now provide insight into the similarities and differences between the molecular cascades that occur during natural death of NPC and death of the same cells induced by DNA-damaging chemicals and γ-radiation. They performed complementary cell culture and in vivo studies of NPC death in mice lacking proteins that play pivotal roles in cell apoptosis, including the tumor suppressor protein p53, the BCL-2 family members BAX (pro-apoptotic) and BCL-2 and BCL-x (anti-apoptotic) and members of the caspase family of apoptosis effector proteins (caspases 3 and 9). The requirements for death that is induced by the DNA-damaging agent AraC and by γ-radiation were different to those required for naturally occurring death of NPC: death triggered by chemical- and radiation-induced DNA damage required p53 and caspase-9, whereas natural cell death did not.The new findings raise several questions, including is the DNA damage that is observed in NPC undergoing natural cell death a trigger for cell death, or is it merely a consequence of the death process? Recent findings have shown that deficiency of DNA repair enzymes results in excessive apoptosis of NPC in developing mouse embryos 2xCell birth, cell death, cell diversity and DNA breaks: how do they all fit together?. Gilmore, E.C. et al. Trends Neurosci. 2000; 23: 100–105Abstract | Full Text | Full Text PDF | PubMed | Scopus (78)See all References2 suggesting that accumulation of DNA damage is sufficient to trigger developmental death in the nervous system. Does turning off a DNA protection or repair mechanism trigger a different cell-death cascade compared with DNA damage induced by exogenous factors? That DNA damage is necessary for apoptosis of NPC during brain development has been suggested by recent studies of telomerase, an enzyme that adds a six-base DNA repeat onto chromosome ends (telomeres). Levels of telomerase activity dramatically decrease in embryonic mouse cerebral cortex during the time period when death of NPC occurs 3xThe catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. Fu, W. et al. J. Mol. Neurosci. 2000; 14: 3–15Crossref | PubMedSee all References3. Telomerase can protect cells against DNA damage-induced apoptosis, consistent with a similar mechanism for promoting the survival of NPC.These studies suggest that there are differences in the biochemical cascades responsible for the neural cell deaths that occur at different stages of development. The differences might be related to aspects of the cell cycle because NPC are mitotic, whereas death associated with synaptogenesis occurs in postmitotic cells. Perhaps differential expression of pro- and anti-apoptotic regulatory proteins accounts for their differential involvement in particular types of developmental cell death. Another possibility is that the stimulus for death of NPC, which is currently unknown, could be quite different from the insufficient neurotrophic factor signaling that might trigger apoptosis in differentiated neurons. Finally, it will be of interest to determine the contributions of DNA damage to neuronal apoptosis in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.
Read full abstract